Secondary Logo

Journal Logo

October 2020 - Volume 99 - Issue 10

  • Walter R. Frontera, MD, PhD
  • 0894-9115
  • 1537-7385
  • 12 issues / year
  • Sports Sciences 49/85, Rehabilitation 26/68
  • 1.838

October 2020

Dear AJPM&R Readers,

During the last few decades, the interest in the used of biologics in medicine has increased significantly.  Broadly speaking, biologics are products derived from human, animal tissue, or microorganisms. It has been proposed that some of these products can be used successfully in the treatment of a number of health conditions including many affecting the musculoskeletal system and treated by physiatrists.  The enthusiasm for this therapeutic approach is very high but we should be cautious and make sure that practice follows the evidence; not the other way. In this issue of the AJPM&R, Kubrova and colleagues summarize and evaluate the available evidence of the potential effectiveness of injectable biologics.   It is encouraging to see the level of research activity on the topic. However, many questions remain unanswered and the regulatory environment needs further clarification. Conceptually, this is a very promising intervention, but clinical research needs to test our assumptions and hypotheses. 

I hope you will enjoy reading this month's issue of the AJPM&R!

Walter R. Frontera, MD, PhD, FRCP
Editor-in-Chief

Current Issue Highlights











March 2020 - Volume 99 - Supplement 1 3
Published March 2020
Other Supplements